In vitro and in vivo assessment of sensitivity to ara-C in myeloid leukemias.
D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D001973:Bromodeoxyuridine / Q000378:metabolism; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004247:DNA / Q000096:biosynthesis; D004351:Drug Resistance; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007124:Immunoenzyme Techniques; D007399:Interphase; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged
D003561:Cytarabine; D004247:DNA; D001973:Bromodeoxyuridine